Olmesartan Plus Tablet 20/12.5 mg

Adult dose

This medication is administered once daily at a dose of one tablet without regard to meals when blood pressure is not adequately controlled. Dosage may be adjusted every 2-4 weeks based on the patient's blood pressure response. For the elderly, it is advisable to start with the lowest dose, taking into account kidney function, cardiac function, comorbidities, and concomitant medications. For patients with renal impairment, including mild and moderate (creatinine clearance >30 mL/min).

Child dose

Safety and efficacy in children have not been established.

This medication can cause serious harm to the fetus or newborn if administered to women during the second or third trimester of pregnancy, thus it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to any components of this medication or those with certain kidney diseases, liver diseases, or electrolyte imbalances should not use it. Patients with very low blood pressure or reduced blood volume should be closely monitored before starting this medication, and appropriate action should be taken immediately if symptoms of hypotension appear. Patients with impaired kidney function or those who have undergone kidney transplantation should have electrolytes and kidney function tested regularly while taking this medication. Patients with severely impaired liver function or certain heart diseases should exercise caution when using this medication. This medication may increase the risk of skin cancer, so it is essential to avoid sun exposure and consult a doctor immediately if any skin abnormalities occur. Dizziness or drowsiness may occur during treatment, therefore it's advisable to avoid driving or operating hazardous machinery. Interactions may occur when taken with other antihypertensive medications, diuretics, or potassium supplements, so patients should consult their doctor or pharmacist. This medication is not recommended for breastfeeding women, and if necessary, breastfeeding should be stopped or the medication should be discontinued. Safety in children has not been established, thus caution is required for use. In case of overdose, symptoms such as low blood pressure, electrolyte imbalance, and dehydration may occur, necessitating immediate medical treatment. For the elderly, it is safest to start at a low dose considering the decline in kidney and liver function.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, peeling skin, pain in the oral/ocular mucosa, shortness of breath or difficulty breathing, asthmatic attacks, respiratory abnormalities with cough and fever, jaundice (yellowing of skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion of consciousness, visual disturbances, paralysis, and changes in urination.

Mild side effects

• Nausea
• vomiting
• diarrhea
• abdominal pain
• indigestion
• gastroenteritis
• headache
• dizziness
• fatigue
• drowsiness

This medication should be stored in a tightly closed container to protect it from air and moisture and is safely stored at room temperature between 1 and 25 degrees Celsius.

Appearance

This medication is a round film-coated tablet that is light orange in color.

Package unit

30 tablets/bottle, 300 tablets/bottle